These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 32170980)
1. Cryptic aberrations may allow more accurate prognostic classification of patients with myelodysplastic syndromes and clonal evolution. Svobodova K; Lhotska H; Hodanova L; Pavlistova L; Vesela D; Belickova M; Vesela J; Brezinova J; Sarova I; Izakova S; Lizcova L; Siskova M; Jonasova A; Cermak J; Michalova K; Zemanova Z Genes Chromosomes Cancer; 2020 Jul; 59(7):396-405. PubMed ID: 32170980 [TBL] [Abstract][Full Text] [Related]
2. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes. Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439 [TBL] [Abstract][Full Text] [Related]
3. Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes. Abáigar M; Robledo C; Benito R; Ramos F; Díez-Campelo M; Hermosín L; Sánchez-Del-Real J; Alonso JM; Cuello R; Megido M; Rodríguez JN; Martín-Núñez G; Aguilar C; Vargas M; Martín AA; García JL; Kohlmann A; Del Cañizo MC; Hernández-Rivas JM PLoS One; 2016; 11(10):e0164370. PubMed ID: 27741277 [TBL] [Abstract][Full Text] [Related]
4. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression. Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343 [TBL] [Abstract][Full Text] [Related]
5. Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes. Qin Y; Zhang H; Feng L; Wei H; Wu Y; Jiang C; Xu Z; Zhu H; Liu T Ann Med; 2022 Dec; 54(1):2627-2636. PubMed ID: 36148999 [TBL] [Abstract][Full Text] [Related]
6. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome. Volkert S; Kohlmann A; Schnittger S; Kern W; Haferlach T; Haferlach C Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299 [TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms. Jankowska AM; Szpurka H; Tiu RV; Makishima H; Afable M; Huh J; O'Keefe CL; Ganetzky R; McDevitt MA; Maciejewski JP Blood; 2009 Jun; 113(25):6403-10. PubMed ID: 19372255 [TBL] [Abstract][Full Text] [Related]
8. Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value. Smith AE; Mohamedali AM; Kulasekararaj A; Lim Z; Gäken J; Lea NC; Przychodzen B; Mian SA; Nasser EE; Shooter C; Westwood NB; Strupp C; Gattermann N; Maciejewski JP; Germing U; Mufti GJ Blood; 2010 Nov; 116(19):3923-32. PubMed ID: 20693430 [TBL] [Abstract][Full Text] [Related]
10. DOES THE PATTERN OF CLONAL EVOLUTION IN THE KARYOTYPE OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES DEPEND ON THE TYPE OF THE PRIMARY CHROMOSOMAL ABERRATIONS? Angelova S; Spassov B; Nikolova V; Christov I; Tzvetkov N; Simeonova M Tsitol Genet; 2015; 49(4):17-24. PubMed ID: 26419065 [TBL] [Abstract][Full Text] [Related]
12. Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis. Neukirchen J; Lauseker M; Hildebrandt B; Nolting AC; Kaivers J; Kobbe G; Gattermann N; Haas R; Germing U Cancer; 2017 Dec; 123(23):4608-4616. PubMed ID: 28746789 [TBL] [Abstract][Full Text] [Related]
13. High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS). Mohamedali AM; Gäken J; Ahmed M; Malik F; Smith AE; Best S; Mian S; Gaymes T; Ireland R; Kulasekararaj AG; Mufti GJ Leukemia; 2015 Sep; 29(9):1928-38. PubMed ID: 25943179 [TBL] [Abstract][Full Text] [Related]
14. A genetic development route analysis on MDS subset carrying initial epigenetic gene mutations. Li X; Xu F; Wu LY; Zhao YS; Guo J; He Q; Zhang Z; Chang CK; Wu D Sci Rep; 2020 Jan; 10(1):826. PubMed ID: 31964915 [TBL] [Abstract][Full Text] [Related]
15. Combined comparative genomic hybridization and single-nucleotide polymorphism array detects cryptic chromosomal lesions in both myelodysplastic syndromes and cytopenias of undetermined significance. Evans AG; Ahmad A; Burack WR; Iqbal MA Mod Pathol; 2016 Oct; 29(10):1183-99. PubMed ID: 27389314 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes. Yan X; Wang L; Jiang L; Luo Y; Lin P; Yang W; Ren Y; Ma L; Zhou X; Mei C; Ye L; Xu G; Xu W; Yang H; Lu C; Jin J; Tong H Cancer Med; 2021 Mar; 10(5):1759-1771. PubMed ID: 33609081 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive array CGH of normal karyotype myelodysplastic syndromes reveals hidden recurrent and individual genomic copy number alterations with prognostic relevance. Thiel A; Beier M; Ingenhag D; Servan K; Hein M; Moeller V; Betz B; Hildebrandt B; Evers C; Germing U; Royer-Pokora B Leukemia; 2011 Mar; 25(3):387-99. PubMed ID: 21274003 [TBL] [Abstract][Full Text] [Related]
18. Identify latent chromosomal aberrations relevant to myelodysplastic syndromes. Song Q; Chu Y; Yao Y; Peng M; Yang W; Li X; Huang S Sci Rep; 2017 Sep; 7(1):10354. PubMed ID: 28871208 [TBL] [Abstract][Full Text] [Related]
19. Detailed analysis of clonal evolution and cytogenetic evolution patterns in patients with myelodysplastic syndromes (MDS) and related myeloid disorders. Schanz J; Cevik N; Fonatsch C; Braulke F; Shirneshan K; Bacher U; Haase D Blood Cancer J; 2018 Mar; 8(3):28. PubMed ID: 29515104 [TBL] [Abstract][Full Text] [Related]
20. Clonal hematopoiesis of indeterminate potential-associated mutations and risk of comorbidities in patients with myelodysplastic syndrome. Naqvi K; Sasaki K; Montalban-Bravo G; Alfonso Pierola A; Yilmaz M; Short N; Assi R; Jabbour E; Ravandi F; Kadia T; Pierce S; Takahashi K; Nogueras Gonzalez G; Kanagal-Shamanna R; Patel K; Soltysiak KA; Kantarjian HM; Garcia-Manero G Cancer; 2019 Jul; 125(13):2233-2241. PubMed ID: 30861111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]